Krushisharang Agriclinic Profile
Key Indicators
- Authorised Capital ₹ 6.20 M
as on 07-12-2024
- Paid Up Capital ₹ 6.20 M
as on 07-12-2024
- Company Age 3 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.50 M
as on 07-12-2024
- Revenue 692.76%
(FY 2023)
- Ebitda -196.08%
(FY 2023)
- Net Worth 141.47%
(FY 2023)
- Total Assets 714.91%
(FY 2023)
About Krushisharang Agriclinic
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.20 M and a paid-up capital of Rs 6.20 M.
The company currently has active open charges totaling ₹9.50 M.
Harshitbhai Gajera and Hirenkumar Patoliya serve as directors at the Company.
- CIN/LLPIN
U01110GJ2021PTC125554
- Company No.
125554
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Sep 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Amreli, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Krushisharang Agriclinic Private Limited offer?
Krushisharang Agriclinic Private Limited offers a wide range of products and services, including Seeds and Plant Saplings, Bean Seeds, Cereals & Food Grains, Chane, Insecticides and Pesticides, Fungicides, Fertilizers and Soil Additives, Organic Fertilizers and Manure, Dry Fruits & Nuts, Peanut.
Who are the key members and board of directors at Krushisharang Agriclinic?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hirenkumar Patoliya  | Director | 13-Sep-2021 | Current |
| Harshitbhai Gajera | Director | 13-Sep-2021 | Current |
Financial Performance of Krushisharang Agriclinic.
Krushisharang Agriclinic Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 692.76% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 141.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Krushisharang Agriclinic?
Unlock access to Krushisharang Agriclinic's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Dec 2023 | ₹9.50 M | Open |
How Many Employees Work at Krushisharang Agriclinic?
Krushisharang Agriclinic has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Krushisharang Agriclinic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krushisharang Agriclinic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
